Skip to main content
Clinical Trials/NCT02179385
NCT02179385
Unknown
Not Applicable

Coaching for Health to Achieve New Goals in Empowerment for Diabetes

Clalit Health Services0 sites300 target enrollmentJune 2014
ConditionsType 2 Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
Clalit Health Services
Enrollment
300
Primary Endpoint
Clinical composite
Last Updated
10 years ago

Overview

Brief Summary

CHANGE-D objectives are to evaluate to what extent personal coaching for healthy lifestyle and treatment adherence improves clinical outcomes among uncontrolled diabetic patients.

Evaluate to what extent personal coaching for healthy lifestyle and treatment adherence improves self treatment among uncontrolled diabetic patients.

Detailed Description

Research Group 300 type 2 diabetics: 150 from Jewish sector and 150 from Arab sector will be recruited from 7-10 clinics in each district: North District and Haifa District A personal coaching intervention will be tailored from the offered tools: Face to face, group, telephone Participants will be monitored for clinical and self treatments outcomes Comparison Group 300 patients with similar characteristics to the research group will receive Clalit's standard of care Participants will be monitored for clinical and self treatments outcomes like the research group

Registry
clinicaltrials.gov
Start Date
June 2014
End Date
June 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Margalit (Margita) Goldfracht

Department Manager of Quality Promotion, Community Medical Division

Clalit Health Services

Eligibility Criteria

Inclusion Criteria

  • Type 2 diabetes
  • At least one oral anti diabetic drug
  • HbA1c above 7.5% ot above 0.5% of personal target
  • Preparedness for change
  • Fluent Hebrew or Arabic

Exclusion Criteria

  • Type 1 diabetes
  • Pregnancy or lactation
  • Incompetency to sign consent
  • Participation in another clinical trial
  • Unstable psychotic disease
  • Complex health condition

Outcomes

Primary Outcomes

Clinical composite

Time Frame: 0, 6, 12, 18 months from randomization

Change from baseline in a composite endpoint of HbA1c, BMI, Blood Pressure, Lipids at 6, 12 and 18 months from randomization

Secondary Outcomes

  • Change in Self Treatment Score(0, 6, 12, 18 months from randomization)
  • Change in Self Efficacy Score(0, 6, 12, 18 months from randomization)

Similar Trials